Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIL-11 in Women With Type 1 VWD and Refractory Menorrhagia
NCT00524342Phase 2Completed
- Start
- Jan 2008
- Primary completion
- Dec 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of oprelvekin in Von Willebrand disease type 1. Started Jan 2008; status: completed.
02
Drugs
oprelvekin
03
Conditions
Von Willebrand disease type 1
Beyond the preview
Go deeper on NCT00524342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524342.